Drug profile · INN
dextrothyroxine sodium
CHOLOXIN
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
dextrothyroxine sodium (CHOLOXIN) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.
Key facts
INN dextrothyroxine sodium
Brand CHOLOXIN
Route ORAL
Formulation TABLET
Frequently asked questions
What is dextrothyroxine sodium?
dextrothyroxine sodium (CHOLOXIN) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for dextrothyroxine sodium?
CHOLOXIN is a marketed brand name for dextrothyroxine sodium. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of dextrothyroxine sodium?
dextrothyroxine sodium has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.